Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
CALL
Jabil
JBL
$38B
| $11.5M | ﹤0.01% |
359,800
-7,200
| -2% | -$207K |
|
1927
Nektar Therapeutics
NKTR
$2.47B
| $11.5M | ﹤0.01% |
33,195
+1,490
| +5% | +$465K |
|
1928
CALL
Zebra Technologies
ZBRA
$17.8B
| $11.5M | ﹤0.01% |
45,000
-7,500
| -14% | -$1.76M |
|
1929
PUT
Labcorp
LH
$25.8B
| $11.5M | ﹤0.01% |
80,665
+35,618
| +79% | +$4.93M |
|
1930
PUT
Equifax
EFX
$21.2B
| $11.5M | ﹤0.01% |
66,900
+31,700
| +90% | +$4.7M |
|
|
LITS
1931
Lite Strategy Inc
LITS
$30.2M
| $11.5M | ﹤0.01% |
138,923
+86,164
| +163% | +$5.22M |
|
1932
PUT
VeriSign
VRSN
$25.7B
| $11.5M | ﹤0.01% |
55,400
+36,100
| +187% | +$7.49M |
|
1933
Annaly Capital Management
NLY
$17.6B
| $11.4M | ﹤0.01% |
435,943
-872,554
| -67% | -$21.6M |
|
1934
PUT
Progressive
PGR
$122B
| $11.4M | ﹤0.01% |
142,600
+97,200
| +214% | +$7.59M |
|
|
GBIO
1935
DELISTED
Generation Bio
GBIO
| $11.4M | ﹤0.01% |
+54,310
| New | +$12.1M |
|
1936
PUT
Papa John's
PZZA
$799M
| $11.4M | ﹤0.01% |
143,600
-2,400
| -2% | -$179K |
|
1937
PUT
WEX
WEX
$6.54B
| $11.4M | ﹤0.01% |
69,100
+51,900
| +302% | +$7.12M |
|
1938
CALL
Welltower
WELL
$170B
| $11.4M | ﹤0.01% |
220,300
+89,900
| +69% | +$4.42M |
|
|
AJRD
1939
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $11.4M | ﹤0.01% |
287,300
+258,600
| +901% | +$10.8M |
|
1940
PUT
F5
FFIV
$22.8B
| $11.4M | ﹤0.01% |
81,600
+24,100
| +42% | +$3.24M |
|
1941
State Street DoubleLine Total Return Tactical ETF
TOTL
$4B
| $11.4M | ﹤0.01% |
+229,133
| New | +$11.2M |
|
1942
Coty
COTY
$2.51B
| $11.3M | ﹤0.01% |
2,537,679
+746,166
| +42% | +$3.62M |
|
1943
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$430M
| $11.3M | ﹤0.01% |
1,582,000
+1,492,672
| +1,671% | +$10.5M |
|
1944
B2Gold
BTG
$6.79B
| $11.3M | ﹤0.01% |
1,992,332
+1,232,304
| +162% | +$6.18M |
|
1945
Verisk Analytics
VRSK
$23.6B
| $11.3M | ﹤0.01% |
66,402
-1,277,530
| -95% | -$202M |
|
1946
PUT
Energy Transfer Partners
ET
$72.5B
| $11.3M | ﹤0.01% |
1,586,900
+262,700
| +20% | +$1.95M |
|
1947
iShares Core MSCI International Developed Markets ETF
IDEV
$32.7B
| $11.3M | ﹤0.01% |
220,948
-705,258
| -76% | -$34.1M |
|
|
BHVN
1948
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $11.3M | ﹤0.01% |
154,400
+38,200
| +33% | +$2.03M |
|
|
1949
Energy Transfer Partners
ET
$72.5B
| $11.3M | ﹤0.01% |
1,585,205
+1,108,653
| +233% | +$8.22M |
|
1950
Replimune Group
REPL
$1.4B
| $11.3M | ﹤0.01% |
452,711
-39,167
| -8% | -$693K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.